$PVCT, Shares of Provectus Biopharmaceuticals,
Post# of 23098
Shares of Provectus Biopharmaceuticals, Inc. (NYSE

The firm’s price to book was 0.92, which can be compared with current price to get idea about under or overvalue of stock. The float short ration was 0.77%; as compared to Short Ratio were 0.40. The firm has institutional ownership of 6.20%, while insider ownership included 5.78%. PVCT attains analyst recommendation of 2.00 with week’s performance of 112.35%.


NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
